CNBG
Was concerned and asked Fred about Wuhan development. I really admire him. He's a very upfront guy. Here's what he said. Hi Steve, I have not heard anything at my end that would cause me to worry regarding CNBG. From what I know, we continue to work very closely with our partners in China (CNBG) and also in Taiwan (Hematech). I believe that the progress recently realized by Prometic both from the manufacturing and regulatory pathways with our PPPS process and plasma purification facility combined with the FDA favorable stance for our PPPS process will also prove to be useful for their own regulatory filings as well since there has been a constant exchange of information between the 2 organizations. I do not have an exact timeline just yet as to when they will start filing their INDs with their regulatory body, so I cannot provide more info on this at the moment. As important as CNBG is for our base case and product sales (resin sales and royalties on therapeutic sales in China), I also believe that we will see even more significant growth from our own plasma derived therapeutics once they are approved and start to be commercialized. Again, from what I know, it is still the plan to end up with up to 3 plasma purification facility in China over the coming years. Rest assured that we will provide any update as soon as they become available. Tks Best regards, Fred